Effects of Ultrasound Cycloplasty in Glaucoma Patients:6-Month Results From a Prospective Clinical Study [PDF]
Liu Li +4 more
openalex +1 more source
Improvement in Clinical Outcomes, Physical Function, and Bodily Pain Following a 12 Week Course of Intermittent Pneumatic Compression Therapy in Patients with Chronic Venous Ulcers: Results of an Observational Longitudinal Retrospective Study [PDF]
Eric Lullove, Oscar M. Alvarez
openalex +1 more source
Peroxidasin enables melanoma immune escape by inhibiting natural killer cell cytotoxicity
Peroxidasin (PXDN) is secreted by melanoma cells and binds the NK cell receptor NKG2D, thereby suppressing NK cell activation and cytotoxicity. PXDN depletion restores NKG2D signaling and enables effective NK cell–mediated melanoma killing. These findings identify PXDN as a previously unrecognized immune evasion factor and a potential target to improve
Hsu‐Min Sung +17 more
wiley +1 more source
Thiol/Disulfide Homeostasis in Lung Cancer: Insights from a Clinical Study. [PDF]
Karaoğlanoğlu S, Sönmez M, Erdal H.
europepmc +1 more source
Review of: "[Case Study] Low-Level Laser and Its Interface With Sleep Dentistry: Clinical Case Report" [PDF]
Vitor Hugo Panhóca
openalex +1 more source
Randomized clinical study of Gastrografin® administration in patients with adhesive small bowel obstruction (Br J Surg 2003; 90: 542-546) [PDF]
R. Chintamani
openalex +1 more source
This study shows that copy number variations (CNVs) can be reliably detected in formalin‐fixed paraffin‐embedded (FFPE) solid cancer samples using ultra‐low‐pass whole‐genome sequencing, provided that key (pre)‐analytical parameters are optimized.
Hanne Goris +10 more
wiley +1 more source
Correction: A topical nociceutical formulation ameliorates chemotherapy‑induced peripheral neuropathy: a pilot randomized clinical study. [PDF]
Servitja S +20 more
europepmc +1 more source
Single circulating tumor cells (sCTCs) from high‐grade serous ovarian cancer patients were enriched, imaged, and genomically profiled using WGA and NGS at different time points during treatment. sCTCs revealed enrichment of alterations in Chromosomes 2, 7, and 12 as well as persistent or emerging oncogenic CNAs, supporting sCTC identity.
Carolin Salmon +9 more
wiley +1 more source

